Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma

Published:2016-04-07 Issue:23 Volume:7 Page:35412-35422
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Jing-hua¹²³,Wang Hua¹²³,Wang Yan-jun²³⁴,Xia Zhong-jun¹²³,Huang Hui-qiang²³⁵,Jiang Wen-qi²³⁵,Lu Yue¹²³

Affiliation:

1. Department of Hematological Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China

2. State Key Laboratory of Oncology in South China, Guangzhou, China

3. Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

4. Department of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, China

5. Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades;Chemotherapy;2023-11-20

2. Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma;Clinical and Translational Oncology;2023-06-23

3. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase;Cell Death & Disease;2023-05-09

4. Diagnostic and prognostic value of pretreatment PET/CT in extranodal natural killer/T-cell lymphoma: a retrospective multicenter study;Journal of Cancer Research and Clinical Oncology;2023-05-06

5. A phase II study of sintilimab, anlotinib, and pegaspargase sandwiched with radiotherapy as first‐line therapy in patients with newly diagnosed, stage I–II extranodal natural‐killer/T‐cell lymphoma;American Journal of Hematology;2023-04-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3